Compound
One tablet contains:
active ingredient - meglumine acridone acetate in terms of acridone acetic acid - 150.00 mg, obtained according to the following recipe: acridone acetic acid - 150.00 mg, meglumine (N-methylglucamine) - 146.00 mg;

Indications
In adults in complex therapy:
     influenza and acute respiratory diseases;
     herpetic infection.
In children starting from four years of age in complex therapy:
     influenza and acute respiratory diseases;
     herpetic infection.
In children over four years of age for the prevention of influenza and acute respiratory diseases.
Use during pregnancy and breastfeeding
The use of the drug during pregnancy and breastfeeding is contraindicated.

Contraindications
Pregnancy, breastfeeding, children under 4 years of age (due to imperfect swallowing), individual intolerance to the components of the drug, decompensated cirrhosis of the liver.

CAREFULLY
For diseases of the digestive system in the acute stage (erosion, gastric and/or duodenal ulcers, gastritis and duodenitis) and a history of allergic reactions before taking the drug, be sure to consult your doctor.

Storage conditions
In a place protected from light at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Best before date
2 years. Do not use after the expiration date stated on the packaging.